The detailed information for PTAB case with proceeding number IPR2018-00122 filed by Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. against Gilead Pharmasset LLC et al. on Oct 26, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2018-00122
Filing Date
Oct 26, 2017
Petitioner
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al.
Respondent
Gilead Pharmasset LLC et al.
Status
Institution Denied
Respondent Application Number
13099671
Respondent Tech Center
1600
Respondent Patent Number
8334270
Institution Decision Date
May 21, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Jun 26, 2018PAPERBOARD

Petitioner's Request for Refund of Post-Institution Fees

Jun 20, 2018PAPERPETITIONER

Denying Institution of Inter Partes Review 35 U.S.C. sec 314(a)

May 21, 2018PAPERBOARD

Patent Owner's Preliminary Response

Feb 28, 2018PAPERPATENT OWNER

FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir

Feb 28, 2018EXHIBITPATENT OWNER

Hepatitis C Killing More Americans than HIV: Studies

Feb 28, 2018EXHIBITPATENT OWNER

America¿¿¿s Overspend: How the Pharmaceutical Patent Problem is Fueling High Drug Prices

Feb 28, 2018EXHIBITPATENT OWNER

FDA Approves Gilead¿¿¿s Hepatitis C Drug

Feb 28, 2018EXHIBITPATENT OWNER

Discovery of a ¿¿-D-2¿¿¿-Deoxy-2¿¿¿-¿¿-Cmethyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus

Feb 28, 2018EXHIBITPATENT OWNER

Pro-Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates.

Feb 28, 2018EXHIBITPATENT OWNER

Nucleoside Analog Inhibitors of Hepatitis C Virus Replication

Feb 28, 2018EXHIBITPATENT OWNER

Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph

Feb 28, 2018EXHIBITPATENT OWNER

HARVONI¿¿ label

Feb 28, 2018EXHIBITPATENT OWNER

Clofarabine: From Design to Approval

Feb 28, 2018EXHIBITPATENT OWNER

I-MAK: Our People

Feb 28, 2018EXHIBITPATENT OWNER

Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection

Feb 28, 2018EXHIBITPATENT OWNER

Hepatitis C Deserves the Attention

Feb 28, 2018EXHIBITPATENT OWNER

F.D.A. Approves Pill to Treat Hepatitis C

Feb 28, 2018EXHIBITPATENT OWNER

Review Article: Investigational Agents for Chronic Hepatitis C

Feb 28, 2018EXHIBITPATENT OWNER

Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2¿¿¿-C-Methylcytidine

Feb 28, 2018EXHIBITPATENT OWNER

Prodrugs of Phosphates, Phosphonates, and Phosphinates

Feb 28, 2018EXHIBITPATENT OWNER

ERRATA

Nov 28, 2017PAPERBOARD

NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE

Nov 27, 2017PAPERBOARD

EXPUNGED

Nov 25, 2017PAPERBOARD

Patent Owner's Mandatory Notices

Nov 9, 2017PAPERPATENT OWNER

Patent Owner Power of Attorney

Nov 9, 2017PAPERPATENT OWNER

Corrected Exhibit List

Oct 31, 2017PAPERPETITIONER

Power of Attorney

Oct 26, 2017PAPERPETITIONER

Curriculum Vitae of Joseph M. Fortunak, Ph.D.

Oct 26, 2017EXHIBITPETITIONER

Petition for Inter Partes Review

Oct 26, 2017PAPERPETITIONER

U.S. Patent No. 8,334,270

Oct 26, 2017EXHIBITPETITIONER

Sofia

Oct 26, 2017EXHIBITPETITIONER

Ma

Oct 26, 2017EXHIBITPETITIONER

Clark 147

Oct 26, 2017EXHIBITPETITIONER

Clark 2005

Oct 26, 2017EXHIBITPETITIONER

Perrone

Oct 26, 2017EXHIBITPETITIONER

McGuigan 327

Oct 26, 2017EXHIBITPETITIONER

Wagner

Oct 26, 2017EXHIBITPETITIONER

Prusoff

Oct 26, 2017EXHIBITPETITIONER

McGuigan 2006

Oct 26, 2017EXHIBITPETITIONER

McGuigan 1994

Oct 26, 2017EXHIBITPETITIONER

Cahard

Oct 26, 2017EXHIBITPETITIONER

Declaration of Joseph M. Fortunak, Ph.D.

Oct 26, 2017EXHIBITPETITIONER